Related Experiment Video
Updated: Sep 26, 2025

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
Published on: July 8, 2025
Current Landscape of Coccidioidomycosis
Ryan Boro1, Prema C Iyer1, Maciej A Walczak2
1Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA 15213, USA.
Valley fever (coccidioidomycosis) is spreading and increasing. This review covers its epidemiology, treatments, diagnostics, and interactions with COVID-19, highlighting future research needs.
Area of Science:
- Mycology
- Infectious Diseases
- Epidemiology
Background:
- Coccidioidomycosis, or Valley fever, is a fungal infection endemic to the southwestern US.
- Increasing geographic range and prevalence of coccidioidomycosis are observed.
- The disease presents diagnostic challenges and potential overlaps with COVID-19.
Purpose of the Study:
- To review the latest information on coccidioidomycosis.
- To cover epidemiology, pharmaceutical treatments, diagnostic concerns, and COVID-19 interactions.
- To identify future research and development directions.
Main Methods:
- Literature review of recent studies on coccidioidomycosis.
- Compilation of data on disease trends, prevalence, and geographical spread.
- Analysis of current and emerging therapeutic and diagnostic strategies.
Main Results:
- Coccidioidomycosis is expanding beyond its traditional endemic areas.
- New pharmaceutical agents are in development for treatment.
- Understanding the interplay between coccidioidomycosis and COVID-19 is crucial, especially in vulnerable populations.
Conclusions:
- Current diagnostic and therapeutic strategies for coccidioidomycosis require ongoing evaluation.
- Further research is needed to address the increasing prevalence and geographical spread.
- Development of novel treatments and improved diagnostics is essential for managing coccidioidomycosis.
More Related Videos
10:06Efficient Method for Imaging Murine Lungs that Preserves Spatial Dynamics of Fungal Spores in the Airways
Published on: December 13, 2024
15:01Confocal Laser Scanning Microscopy-Based Quantitative Analysis of Aspergillus fumigatus Conidia Distribution in Whole-Mount Optically Cleared Mouse Lung
Published on: September 18, 2021
Related Concept Videos
Fungal Phylum Microsporidia
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...